Stockreport

FDA Lifts Clinical Hold on Iovance's (IOVA) Lung Cancer Study [Yahoo! Finance]

Iovance Biotherapeutics, Inc.  (IOVA) 
Last iovance biotherapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: iovance.com
PDF investigational tumor-infiltrating lymphocyte (TIL) therapy, LN-145, in certain non-small cell lung cancer (NSCLC) patients. This clinical hold was placed by the FDA l [Read more]